Gastric banding, metformin “equal” for slowing early T2DM progression

Clinical Endocrinology News highlighted a study by Thomas Buchanan, MD, professor of medicine, comparing gastric banding and metformin for improving insulin sensitivity in patients with early Type 2 diabetes in the following link:

https://www.mdedge.com/clinicalendocrinologynews/article/176467/diabetes/gastric-banding-metformin-equal-slowing-early-t2dm

Welcome to DORI

Welcome to the Diabetes & Obesity Research Institute (DORI) at the University of Southern California. Established in 2012, the DORI is a multi-disciplinary collaborative of investigators seeking to link basic, clinical, and public health research to advance the understanding of obesity and its relationship to type II diabetes. The Institute was designed to foster interactions across disciplinary boundaries; embrace methods and techniques from diverse fields of study; and develop effective approaches to risk assessment, prevention and treatment of the international co-epidemics of diabetes and obesity.
Upcoming Events
1. Accepting Abstracts for DORI’s Symposium Oral & Poster Presentations by Students, Fellows, & Postdocs – Due Nov. 1, 2019
  
  September 14 - November 1
2. Shared DORI Seminar/Grand Rounds – Michael Rosenbaum, MD
  
  November 12 @ 12:00 pm - 1:00 pm
3. Shared USC DORI & CHLA Saban Research Institute Seminar – Karen Peterson, D.Sc.
  
  December 11 @ 12:00 pm - 1:00 pm
4. Save the Date: DORI’s 7th Annual Symposium is Feb. 25 & 26, 2020
  
  February 25, 2020 - February 26, 2020
View All Events

Contact Form

Gastric banding, metformin “equal” for slowing early T2DM progression

Welcome to DORI

Upcoming Events

Accepting Abstracts for DORI’s Symposium Oral & Poster Presentations by Students, Fellows, & Postdocs – Due Nov. 1, 2019

Shared DORI Seminar/Grand Rounds – Michael Rosenbaum, MD

Shared USC DORI & CHLA Saban Research Institute Seminar – Karen Peterson, D.Sc.

Save the Date: DORI’s 7th Annual Symposium is Feb. 25 & 26, 2020